Ronald C Renaud Jr Translate Bio, Inc. (TBIO) insider trading activity

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held N/A

Ronald C Renaud Jr Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 14 2021	SELL Open market or private sale	$19,122,778 $38.0 p/Share	503,231 Reduced 100.0%	0 Common Stock
Apr 07 2021	BUY Exercise of conversion of derivative security	$66,702 $7.39 p/Share	9,026 Added 1.76%	503,321 Common Stock
Jan 14 2021	BUY Exercise of conversion of derivative security	$44,379 $7.87 p/Share	5,639 Added 1.13%	494,205 Common Stock
Nov 16 2020	BUY Exercise of conversion of derivative security	$417,165 $7.87 p/Share	53,007 Added 9.79%	488,566 Common Stock

ATRA

Atara Biotherapeutics, Inc. Healthcare

IKNA

Ikena Oncology, Inc. Healthcare

Director

CERE

Cerevel Therapeutics Holdings, Inc. Healthcare

President & CEO

UPB

Upstream Bio, Inc.

RCR

Chief Executive Officer

Southn San Francisco, CA

Receive a notification when an Institution or Guru buys or sells TBIO shares.

Notify only if

Value

Get notified when an Translate Bio, Inc. insider buys or sells TBIO shares.

Notify only if

Operation

Value

Type

Receive news related to Translate Bio, Inc.